SEBI issues notice to Fortis arm Escorts Heart Institute in funds diversion case

Fortis Healthcare on Friday said its subsidiary, Escorts Heart Institute and Research Center Ltd, received the notice on April 15, 2021.

Published On 2021-04-17 03:45 GMT   |   Update On 2021-04-17 03:45 GMT

New Delhi: Fortis Healthcare on Friday said its subsidiary, Escorts Heart Institute and Research Center Ltd, has received a notice from capital markets regulator SEBI in the matter related to the alleged diversion of funds from the company by its erstwhile promoters.

"SEBI has issued a notice under Rule 4 of SEBI (Procedure for holding inquiry and imposing penalties) Rules, 1995 read with Section 15-I of Securities and Exchange Board of India Act, 1992 in the matter of Fortis Healthcare Limited to, among others, Escorts Heart Institute and Research Center Limited (EHIRCL)," Fortis Healthcare said in a regulatory filing.

Also Read:Fortis Hospital Kalyan appoints Dr Rahul Pandit to helm strategic development of Critical Care services

Fortis Healthcare on Friday said its subsidiary, EHIRCL, received the notice on April 15, 2021.

"The management and board of the company that was newly constituted after NTK Ventures Pte Ltd (a wholly-owned subsidiary of IHH Healthcare Berhad) became promoters of the company, are evaluating the notice received by EHIRCL, in consultation with its legal advisors," Fortis Healthcare said.

Also Read: SEBI imposes Rs 1 lakh fine on Fortis Healthcare Holdings for disclosure lapses

Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News